Rubrik: Technik
(Treffer aus pharmind, Nr. 11, Seite 1050 (2024))
Bitar K | Kanso A
Distribution and Logistics in Cell and Gene Therapies / Challenges and Solutions · Bitar K, Kanso A · Camelot Management Consultants Middle East
Personalized Therapies Cell and Gene Therapies Supply Chain Regulatory Compliance Distribution Models Critical to the effective delivery of autologous cell and gene therapies is preserving product integrity throughout the supply chain cycle. The unique qualities of these innovative therapeutics, such as their designation as “batch size one”, present challenges not encountered with traditional pharmaceutical products. Autologous therapies, tailored to individual patients, demand meticulous logistics to ensure utmost product integrity. The introduction of closed-loop supply chains (therapy starts at the patient and ends at the patient) imposes new requirements for seamless coordination and traceability. Handling cell and gene therapies involves addressing ...